CCRN
Cross Country Healthcare Inc
NASDAQ: CCRN · HEALTHCARE · MEDICAL CARE FACILITIES
$10.12
-1.46% today
Updated 2026-04-30
Market cap
$323.92M
P/E ratio
—
P/S ratio
0.31x
EPS (TTM)
$-2.93
Dividend yield
—
52W range
$7 – $15
Volume
0.5M
WallStSmart proprietary scores
36
out of 100
Grade: D
Sell
Investment rating
2.0
Growth
F8.5
Quality
A2.5
Profitability
F5.7
Valuation
C+2/9
Piotroski F-Score
Weak
4.2
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$11.67
+15.32%
12-Month target
—
—
Intrinsic (DCF)
$35.09
Margin of safety
+76.43%
1 Strong Buy2 Buy6 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 4.20 — safe zone
+ Free cash flow $16.12M — positive
+ 76.43% below intrinsic value
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at -9.00%
- Revenue declining -23.60% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.80B | $2.02B | $1.34B | $1.05B | $1.05B |
| Net income | $185.98M | $72.63M | $-14.56M | $-94.85M | $-82.93M |
| EPS | — | — | — | — | $-2.93 |
| Free cash flow | $125.26M | $234.52M | $111.40M | $40.09M | $16.12M |
| Profit margin | 6.63% | 3.60% | -1.08% | -9.00% | -9.00% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-31 | VEIZAGA, MARVIN | Buy | 9,043 | — |
| 2026-03-31 | VEIZAGA, MARVIN | Sale | 501 | $9.40 |
| 2026-03-31 | VEIZAGA, MARVIN | Sale | 437 | $9.40 |
Peer comparison
Smart narrative
Cross Country Healthcare Inc trades at $10.12. Our Smart Value Score of 36/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 4.20, it sits in the safe zone. TTM revenue stands at $1.05B. with profit margins at -9.00%. Our DCF model estimates intrinsic value at $35.09.
Frequently asked questions
What is Cross Country Healthcare Inc's stock price?
Cross Country Healthcare Inc (CCRN) trades at $10.12.
Is Cross Country Healthcare Inc overvalued?
Smart Value Score 36/100 (Grade D, Sell). DCF value $35.09.
What is the price target of Cross Country Healthcare Inc (CCRN)?
The analyst target price is $11.67, representing +15.3% upside from the current price of $10.12.
What is the intrinsic value of Cross Country Healthcare Inc (CCRN)?
Based on our DCF model, intrinsic value is $35.09, a +76.4% margin of safety versus $10.12.
What is Cross Country Healthcare Inc's revenue?
TTM revenue is $1.05B.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
4.20 — safe zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.31x
ROE-25.60%
Beta0.34
50D MA$9.35
200D MA$10.90
Shares out0.03B
Float0.03B
Short ratio—
Avg volume0.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—